Holen Sie sich die Stockscreener-App
2.48
2.48%
0.06
Handel nachbörslich:
2.48
Schlusskurs vom Vortag:
$2.42
Offen:
$2.45
24-Stunden-Volumen:
56,888
Relative Volume:
0.40
Marktkapitalisierung:
$22.69M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-27.28M
KGV:
-0.4306
EPS:
-5.76
Netto-Cashflow:
$-18.89M
1W Leistung:
+7.36%
1M Leistung:
+13.24%
6M Leistung:
+15.89%
1J Leistung:
+78.42%
1-Tages-Spanne:
$2.35
$2.55
1-Wochen-Bereich:
$2.2401
$2.75
52-Wochen-Spanne:
$1.0214
$4.98
iBio Inc Stock (IBIO) Company Profile
Firmenname
iBio Inc
Sektor
Branche
Telefon
302-355-0650
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Vergleichen Sie IBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
2.48 | 22.69M | 2.05M | -27.28M | -18.89M | -15.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-28 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-11-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-01-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-06-26 | Eingeleitet | Alliance Global Partners | Buy |
iBio Inc Aktie (IBIO) Neueste Nachrichten
iBio Inc. stock rises Thursday, outperforms market - MarketWatch
iBio Inc. stock falls Wednesday, still outperforms market - MarketWatch
LUCID CAPITAL MARKETS Initiates Coverage of iBio (IBIO) with Buy Recommendation - MSN
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
iBio Inc. stock rises Monday, outperforms market - MarketWatch
Chardan Capital Initiates Coverage of iBio (IBIO) with Buy Recommendation - MSN
iBio Inc. stock falls Friday, underperforms market - MarketWatch
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
iBio Inc. stock outperforms market despite losses on the day - MarketWatch
iBio Inc. stock rises Friday, outperforms market - MarketWatch
iBio Inc. stock rises Wednesday, outperforms market - MarketWatch
iBio Inc. stock falls Monday, underperforms market - MarketWatch
iBio Strengthens Board with Appointment of Two New Independent Directors - GlobeNewswire
iBio Strengthens Board with Key Appointments in Finance, Antibody Discovery - StockTitan
Ikarian Capital, LLC Adjusts Stake in iBio Inc - GuruFocus.com
ADAR1 Capital Management's Strategic Acquisition in iBio Inc - GuruFocus.com
iBio Inc Reports Fiscal Q1 GAAP EPS of -$0.52, Missing Estimates; No Revenue Reported, Aligning with Expectations - GuruFocus.com
iBio Reports Fiscal First Quarter 2025 Financial Results - GlobeNewswire
iBio (NYSE:IBIO) Trading Down 0.6% – Here’s What Happened - Defense World
iBio Inc. stock remains steady Monday, underperforms market - MarketWatch
iBio Unveils AI-Driven Antibody Discovery Strategy - TipRanks
Plant-Based Vaccines Market Is Booming Worldwide 2024-2031 | - openPR
iBio Inc. stock remains steady Thursday, underperforms market - MarketWatch
Finanzdaten der iBio Inc-Aktie (IBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):